Logo image of TACT

TRANSACT TECHNOLOGIES INC (TACT) Stock Fundamental Analysis

USA - NASDAQ:TACT - US8929181035 - Common Stock

4.28 USD
+0.08 (+1.9%)
Last: 11/17/2025, 4:30:01 PM
4.3975 USD
+0.12 (+2.75%)
After Hours: 11/10/2025, 8:00:00 PM
Fundamental Rating

4

Overall TACT gets a fundamental rating of 4 out of 10. We evaluated TACT against 35 industry peers in the Technology Hardware, Storage & Peripherals industry. TACT has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, TACT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

TACT had negative earnings in the past year.
In the past year TACT had a positive cash flow from operations.
TACT had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: TACT reported negative operating cash flow in multiple years.
TACT Yearly Net Income VS EBIT VS OCF VS FCFTACT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

TACT's Return On Assets of -19.38% is on the low side compared to the rest of the industry. TACT is outperformed by 65.71% of its industry peers.
TACT has a Return On Equity (-27.59%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -19.38%
ROE -27.59%
ROIC N/A
ROA(3y)-8.37%
ROA(5y)-9.27%
ROE(3y)-12.56%
ROE(5y)-13.34%
ROIC(3y)N/A
ROIC(5y)N/A
TACT Yearly ROA, ROE, ROICTACT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 -30

1.3 Margins

The Gross Margin of TACT (47.47%) is better than 85.71% of its industry peers.
TACT's Gross Margin has been stable in the last couple of years.
TACT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 47.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.24%
GM growth 5Y0.64%
TACT Yearly Profit, Operating, Gross MarginsTACT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

7

2. Health

2.1 Basic Checks

TACT does not have a ROIC to compare to the WACC, probably because it is not profitable.
TACT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, TACT has more shares outstanding
TACT has a worse debt/assets ratio than last year.
TACT Yearly Shares OutstandingTACT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
TACT Yearly Total Debt VS Total AssetsTACT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

TACT has an Altman-Z score of 3.69. This indicates that TACT is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.69, TACT is in the better half of the industry, outperforming 74.29% of the companies in the same industry.
TACT has a debt to FCF ratio of 0.50. This is a very positive value and a sign of high solvency as it would only need 0.50 years to pay back of all of its debts.
TACT has a Debt to FCF ratio of 0.50. This is amongst the best in the industry. TACT outperforms 91.43% of its industry peers.
A Debt/Equity ratio of 0.10 indicates that TACT is not too dependend on debt financing.
TACT's Debt to Equity ratio of 0.10 is fine compared to the rest of the industry. TACT outperforms 65.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 0.5
Altman-Z 3.69
ROIC/WACCN/A
WACC8.75%
TACT Yearly LT Debt VS Equity VS FCFTACT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

A Current Ratio of 3.08 indicates that TACT has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.08, TACT is in the better half of the industry, outperforming 77.14% of the companies in the same industry.
A Quick Ratio of 2.07 indicates that TACT has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.07, TACT is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.08
Quick Ratio 2.07
TACT Yearly Current Assets VS Current LiabilitesTACT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

4

3. Growth

3.1 Past

TACT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 65.00%, which is quite impressive.
TACT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -40.27%.
Measured over the past years, TACT shows a decrease in Revenue. The Revenue has been decreasing by -1.06% on average per year.
EPS 1Y (TTM)65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)-40.27%
Revenue growth 3Y3.27%
Revenue growth 5Y-1.06%
Sales Q2Q%21.25%

3.2 Future

Based on estimates for the next years, TACT will show a very strong growth in Earnings Per Share. The EPS will grow by 30.94% on average per year.
Based on estimates for the next years, TACT will show a quite strong growth in Revenue. The Revenue will grow by 13.13% on average per year.
EPS Next Y38.8%
EPS Next 2Y30.94%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year18.91%
Revenue Next 2Y13.13%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TACT Yearly Revenue VS EstimatesTACT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
TACT Yearly EPS VS EstimatesTACT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TACT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TACT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TACT Price Earnings VS Forward Price EarningsTACT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, TACT is valued cheaply inside the industry as 91.43% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.15
EV/EBITDA N/A
TACT Per share dataTACT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

TACT's earnings are expected to grow with 30.94% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.94%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for TACT!.
Industry RankSector Rank
Dividend Yield N/A

TRANSACT TECHNOLOGIES INC

NASDAQ:TACT (11/17/2025, 4:30:01 PM)

After market: 4.3975 +0.12 (+2.75%)

4.28

+0.08 (+1.9%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)11-10 2025-11-10/amc
Earnings (Next)03-11 2026-03-11/bmo
Inst Owners52.85%
Inst Owner Change1.45%
Ins Owners4.92%
Ins Owner Change1.33%
Market Cap43.19M
Revenue(TTM)43.38M
Net Income(TTM)-8.63M
Analysts82.86
Price Target5.1 (19.16%)
Short Float %0.08%
Short Ratio0.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)90.2%
Min EPS beat(2)80.39%
Max EPS beat(2)100%
EPS beat(4)4
Avg EPS beat(4)61.24%
Min EPS beat(4)26.47%
Max EPS beat(4)100%
EPS beat(8)8
Avg EPS beat(8)176.94%
EPS beat(12)12
Avg EPS beat(12)263.61%
EPS beat(16)15
Avg EPS beat(16)196.58%
Revenue beat(2)2
Avg Revenue beat(2)11.86%
Min Revenue beat(2)7.79%
Max Revenue beat(2)15.92%
Revenue beat(4)2
Avg Revenue beat(4)2.14%
Min Revenue beat(4)-11.88%
Max Revenue beat(4)15.92%
Revenue beat(8)4
Avg Revenue beat(8)1.16%
Revenue beat(12)8
Avg Revenue beat(12)5.84%
Revenue beat(16)11
Avg Revenue beat(16)5.73%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)60%
EPS NY rev (1m)0%
EPS NY rev (3m)21.05%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)6.94%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.91%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.9
P/FCF 7.15
P/OCF 7.02
P/B 1.38
P/tB 1.51
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)0.6
FCFY13.99%
OCF(TTM)0.61
OCFY14.24%
SpS4.75
BVpS3.1
TBVpS2.84
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -19.38%
ROE -27.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 47.47%
FCFM 12.6%
ROA(3y)-8.37%
ROA(5y)-9.27%
ROE(3y)-12.56%
ROE(5y)-13.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.24%
GM growth 5Y0.64%
F-Score4
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 0.5
Debt/EBITDA N/A
Cap/Depr 14.5%
Cap/Sales 0.23%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.08
Quick Ratio 2.07
Altman-Z 3.69
F-Score4
WACC8.75%
ROIC/WACCN/A
Cap/Depr(3y)63.1%
Cap/Depr(5y)77.66%
Cap/Sales(3y)1.41%
Cap/Sales(5y)2.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y38.8%
EPS Next 2Y30.94%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-40.27%
Revenue growth 3Y3.27%
Revenue growth 5Y-1.06%
Sales Q2Q%21.25%
Revenue Next Year18.91%
Revenue Next 2Y13.13%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-101.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year110.17%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y25.59%
FCF growth 3YN/A
FCF growth 5Y-15.06%
OCF growth 1Y1.47%
OCF growth 3YN/A
OCF growth 5Y-17.43%

TRANSACT TECHNOLOGIES INC / TACT FAQ

What is the ChartMill fundamental rating of TRANSACT TECHNOLOGIES INC (TACT) stock?

ChartMill assigns a fundamental rating of 4 / 10 to TACT.


What is the valuation status of TRANSACT TECHNOLOGIES INC (TACT) stock?

ChartMill assigns a valuation rating of 2 / 10 to TRANSACT TECHNOLOGIES INC (TACT). This can be considered as Overvalued.


How profitable is TRANSACT TECHNOLOGIES INC (TACT) stock?

TRANSACT TECHNOLOGIES INC (TACT) has a profitability rating of 2 / 10.


What is the financial health of TRANSACT TECHNOLOGIES INC (TACT) stock?

The financial health rating of TRANSACT TECHNOLOGIES INC (TACT) is 7 / 10.


Is the dividend of TRANSACT TECHNOLOGIES INC sustainable?

The dividend rating of TRANSACT TECHNOLOGIES INC (TACT) is 0 / 10 and the dividend payout ratio is 0%.